Taiwan FDA registration 3aaa9ac283af64af96f57818a1b691d6
Cutting-edge medical methamphetamine/ecstasy rapid test reagent
TW: 尖端醫 甲基安非他命/搖頭丸快速檢驗試劑
Taiwan·Risk Class 2·Formosa Biomedical Technology Co., Ltd. Yilan Factory·Registered Oct 03, 2018 – Aug 06, 2028ActiveRegistration details
- Analysis ID
- 3aaa9ac283af64af96f57818a1b691d6
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- TAIWAN ADVANCE BIO-PHARMACEUTICAL INC.
Product details
- Intended Use
- This product uses competitive immunochromatography to qualitatively detect methamphetamine/ecstasy in human urine, and the test results can be used for preliminary screening. The threshold standard for methamphetamine/ecstasy is 500 ng/ml. This product can be used by both individuals and professionals.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3610 Methamphetamine testing system
- Import Information
- Domestic;; Contract manufacturing
Dates and status
- Registration Date
- Oct 03, 2018
- Expiry Date
- Aug 06, 2028
About this record
Access comprehensive regulatory information for Cutting-edge medical methamphetamine/ecstasy rapid test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3aaa9ac283af64af96f57818a1b691d6 and manufactured by Formosa Biomedical Technology Co., Ltd. Yilan Factory. The authorized representative in Taiwan is TAIWAN ADVANCE BIO-PHARMACEUTICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices